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Abstract 
Purpose: To investigate the effect of metformin in-ovo injection on blood parameters and adenosine 
monophhosphate-activeed protein kinase (AMPK) gene expression in the liver of pre- and post-hatch 
broilers.  
Methods: A total of 300 fertilized broiler breeders’ eggs (Ross 308) were selected for injection of 
metformin. There were four treatment levels and four replicates. Each replicate contained 15 eggs. 
Treatment involved injecting a solution without metformin (physiological serum), injecting one ml of 2 
mg/l metformin, injecting one ml of 4 mg/l metformin and injecting one ml of 6 mg/l metformin. The first 
experiment was conducted on one-day-old chicks and the second experiment on 42-day-old chicks. 
Blood parameters, including glucose, cholesterol, LDL (low density lipoprotein), HDL (high density 
lipoprotein) and VLDL (very low density lipoprotein) were examined in both the experiments. Gene 
expression was also tested separately.  
Results: In the test on 1-day old chicks, the results of the effect of metformin on AMPK gene 
expression indicate that the treatment caused significantly modified the latter (p <0.05). Furthermore, 
triglyceride, HDL, LDL and VLDL concentrations were significantly reduced by increasing concentration 
of metformin (p <0.05). In the experiment on 42-day old chicks, the effect of metformin on the levels of 
the blood parameters was not significant (p > 0.05).  
Conclusion: Metformin injection into one-day-old chicks activates lipid metabolism in the yolk sac of the 
embryo, resulting in the lipid depletion. However, there was no significant effect on AMPK gene 
expression and blood parameters in 42-day-old chicken due to the long interval between metformin 
injection (42 days).  
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Metformin (N, N-Dimethylimidodicarbonimidic 
diamide) is a chemical drug with a molecular 
weight of 129. 16364 grams per mole and is 
presented as C4H11N5. Metformin is one of the 
oldest and most widely used oral drugs for the 
treatment of type 2 diabetes. The mechanism of 
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action of metformin is such that it creates an 
obstruction in the complex 1 of mitochondrial 
respiratory chain (NADH-ubiquinone oxido-
reductase). Metformin is a biguanide, like 
buformin and phenformin.  
 
The main effect of metformin is reduced hepatic 
glucose production and increased cell sensitivity 
to peripheral insulin; thus it lowers blood sugar. 
Metformin reduced triglycerides [1], non-
esterified fatty acid (NEFA) [2] and results in 
energy supply to the lipids and their oxidation by 
decreasing sensitivity to glucose. Its anti-diabetic 
activity occurs through AMPK activation, reduced 
hepatic glucose and increased glucose uptake in 
skeletal muscles. Metformin activates AMPK 
enzyme by LKB1 gene [3]. 
 
AMPK is an enzyme that plays a key role in 
signaling insulin, the body's energy balance and 
glucose as well as lipid metabolism [4]. AMPK 
activation occurs by physiological stimulations 
such as muscle activity, physiological stress, 
secretion of hormones such as leptin and 
adiponectin, glucose reduction, tissue hypoxia, 
oxidative stress and osmotic shock. AMPK 
activation inhibits gluconeogenesis and 
lipogenesis and leads to energy production 
towards triglyceride oxidation and lipolysis. 
AMPK is activated by 5-aminoimidazole-4-
carboxamide-1-β-d-ribofuranoside (AICAR) and 
metformin [5] and then by inhibiting two key 
genes’ expression by hepatic gluconeogenics 
called PEPCK (Phosphoenolpyruvate 
carboxykinase) and G6Pase (Glucose 6 
phosphatase) it inhibits gluconeogenesis [6]. 
Another method of AMPK activation is AMP 
(Adenosine monophosphate) to ATP (Adenosine 
triphosphate) ratio so that it is activated by 
increasing AMP and decreasing ATP under 
stress conditions [7]. AMPK is a signal path for 
all reactions within the cells. This enzyme 
increases oxidation of fatty acids and produces 
energy. Many researchers have studied the 
effect of metformin on human and rats but few 
studies have been conducted on chickens and 
perhaps the in-ovo injection of metformin and 
analysis of metformin injection’s effect on broilers 
has been addressed for the first time. Therefore, 
the aim of this study was to investigate the effect 
of metformin in-ovo injection on blood 
parameters and AMPK gene expression in the 




Experimental groups  
 
This study was first conducted on chick embryo 
and given the limited resources there is no 
precise injection dosage. In order to ensure that 
the dosage would not be lethal for the chick 
embryo, two pretests were conducted to achieve 
the main and non-lethal dosage to chicken 
embryos. A total of 300 fertilized broilers’ eggs 
(Ross 308) (breeder flock of age 57 weeks) were 
selected after candling the eggs and making sure 
about the fertilized eggs. They were weighed 
individually (average weight 59 ± 1 g). Each 
group consisted of four replications and each 
replication included 15 eggs and the treatment 
consisted of 60 fertilized eggs (a 60-member 
group of the embryonated egg was considered 
positive control without injection). Treatment 
involved injecting a solution without metformin 
(physiology serum as sham control), injecting 
one ml of 2 mg/l metformin, injecting one ml of 4 
mg/l metformin and injecting one ml of 6 mg/l 





Approval was obtained for the animal studies 
from SRB of IAU (ref no. 2356002, 2016, 29.03), 
and international guidelines for animal studies 




To determine the exact location for injecting into 
the amniotic fluid, the blue Kumasi solution was 
injected from the broad side of the egg. On the 
16th day of incubation, all the eggs were candled 
prior to injection and analyzed in terms of fetal 
physiological conditions, fluidity of amniotic fluid 
and fetal motility. To determine the exact location 
for injection into the amniotic fluid, the blue 
Kumasi solution was injected from the broad side 
of the egg. To begin testing, the eggs were 
pierced by pins from the broad side and one ml 
of the solution was injected into the amniotic fluid 
of fertile eggs by a needle on a syringe (21). 
Syringes with 1m volume were used for injection. 
The injected part was disinfected by ethanol 70 
% and blocked with liquid paraffin. 
 
Incubation and hatching process 
 
After injecting metformin, the eggs were 
transferred to the hatcher. Temperature and 
humidity of the hatcher (Petersime Model192, 
Manual) were 37.5 °C and 50 %, respectively. 
The chickens were removed after 508 h when 
only 5 % of the chicks was still not hatched [8]. 
 
Birds and diet 
 
After hatching of 32 chicks, two chicks from each 
replicate and each treatment were transferred to 
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the Pasteur Institute of Iran for conducting 
experiments on gene expression and blood 
parameters (research unit located in the northern 
city of Amol). Also, 160 one-day-old chicks were 
randomly grouped and moved to the breeding 
hall following protocols of the Animal Care 
Committee of the Islamic Azad University 
(Science and Research Branch in Tehran, Iran). 
The chicks were reared in the breeding hall. The 
birds in each experimental group had free access 
to feed and safe water. Environmental conditions 
were the same for all the birds and there were 10 
chicks per square meter. Lighting power was 30 
to 40 lux and there were 23 h of light and 1 h of 
darkness. No medication and vaccination was 
used during the breeding period. The 
compositions of experimental diets (starter, 
grower and finisher) are presented in Table 1. 
Diets were based on UFFDA and nutrition guide 
of Ross 308. 
 









62.72 57.51 55.14 Corn 
30.98 36.43 39.4 Soybean meal 
2.75 2.26 1.3 Soybean oil 
1.3 1.44 1.55 
Di-calcium 
phosphate 
0.96 1.03 1.18 Calcium carbonate 
0.25 0.25 0.25 
Mineral 
supplements 
0.25 0.25 0.25 
Vitamin 
supplements 
0.27 0.3 0.3 DL-methionine 
0.19 0.18 0.24 Lysine 
0.04 0.06 0.1 Threonine 
0.29 0.29 0.29 Salt 
   Chemical composition 
3105 3081 3016 Metabolism  energy (kcal/kg) 
18.25 19.26 21.68 Crude protein (%) 
Composition of each kg of mineral supplement: 40000 
mg manganese, 33880 mg zinc, 20000 mg iron, 4000 
mg copper, 400 mg iodine, 80 mg selenium, and 
100000 milligram choline chloride; The composition of 
each kg of vitamin supplement: 3600000 international 
units of vitamin A, 720 mg vitamin B 1, 2640 mg 
vitamin B 2, 4000 mg nicotinic acid, 1200 mg vitamin B 
6, 400 mg folic acid, 6 mg vitamin B 12, 80000 
International units of vitamin D 3, 7200 international 
units of vitamin E, 800 mg vitamin K 3, 40 mg biotin, 






The weight of each egg and chick body weight as 
well as the body weight to the weight of the eggs 
ratio were determined. Hatchability of the 
fertilized eggs was determined by counting the 
number of hatched chicks in each group. For 
sampling the first stage, 32 one-day-old chicks 
(two chicks were chosen randomly from each 
replicate and each treatment) and blood 
sampling was performed. 1 ml of blood was 
collected from each chick and the chick’s liver 
was removed. Blood samples were centrifuged at 
1500 g for 10 min. The separated blood sera 
were frozen in vials at -20 °C. To measure the 
blood parameters (triglycerides, glucose, HDL, 
LDL and VLDL) Pars Azmoon commercial kits 
were used. AMPK gene expression stages were 
the same for the chickens and hens’ livers. 
 
2nd experiment  
 
At the end of the breeding period, 32 hens and 
roosters, two pieces of each treatment and two 
replications were randomly selected and blood 
sampled. For carcass analysis, five pieces from 
each experimental group were randomly 
selected, weighed and killed by cervical 
dislocation. After filling, the carcass weight 
(without stomach) and the carcass components 
including weights of the liver, spleen and 
pancreas were measured after being removed. 
The livers were sent to the laboratory for gene 
expression tests. 
 
AMPK gene expression studies 
 
100 mg of liver samples with 5 ml phosphate 
buffered saline solution (PBS) with pH=4.7 were 
homogenized manually. After transferring the 
uniform liquid to Eppendorf, 1500×g centrifuge 
was done for 20 min at 4 °C. After centrifugation, 
the supernatant was collected with a swab and 
the lower transparent liquid was evacuated in 
ELISA kit wells by the sampler. 
 
Standardization of kit 
 
Standards included 5, 10, 20, 40, and mIU/L. Kit 
sensitivity in equivalent measure was 0.2 ng/ml. 
The steps and wavelength (450 nm) reading 
were performed according to the instructions by 
Shanghai Crystal day Biotech Co. (Table 2). 
 
Table 2: AMPK gene standardization 
 
120 μl  Standard thinners 




120 μl Standard thinners 




120 μl Standard thinners 




120 μl Standard thinners 




120 μl Standard thinners 
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Evaluation of biochemical parameters 
 
Glucose, cholesterol, LDL, HDL and VLDL were 
examined in both the experiments. Blood 
samples of chickens were collected in tubes 
containing anticoagulant (EDTA) after killing 
them. The samples’ plasma was separated after 
5000×g centrifuging for five minutes and frozen 
inside the micro tubes at -20°C. Blood 
parameters were determined by autoanalyzer 
with Pars Azmoon commercial kits by enzymatic 




The data were analyzed by SAS version 9.1 with 
completely randomized design of four treatment 
types and four replicates (Eq 1). Mean 
comparison was analyzed by Duncan's multiple 




where Yij= amount per view, µ = average 
population, Ti = treatment effect, and eij = effect 




Gene expression (1st experiment) 
 
Tests related to gene expression were conducted 
on the liver of 32 chick after isolation. There was 
a significant difference in the AMPK gene 
expression between treatment with 
concentrations of 2 and 4 ml (p < 0.05) (Table 3). 
 
Table 3: Effect of metformin on AMPK gene 
expression related to the first experiment (n = 32) 
 
Metformin dose  AMPK concentration 
0 ml 23.772ab 
2 ml 25.932a 
4 ml 20.186b 
6 ml 23.768ab 
SEM 1.757 
Note: a-b dissimilar letters in each column and each 
sub-group indicate significant difference (p < 0.05) 
 
Second experiment gene expression  
 
Tests related to gene expression were conducted 
on the liver of 32 chickens after isolation. There 
was no significant difference in the AMPK gene 
expression during treatment (p >0.05) (Table 4). 
Table 4 presents the effect of metformin on 
AMPK gene expression related to the second 
experiment (average data of 32 chicks). In the 
first experiment, the regression coefficient was 
0.9446 and the regression equation y = 0.0125x 
+ 0.1326 while in the second experiment, they 
were 0.9985 and y = 0.0219x - 0.0881. 
 
Table 4: Effect of metformin on AMPK gene 
expression related to the second experiment (mean 
data for 32 chicks) 
 
Metformin dose AMPK concentration 
0 ml 8.091 
2 ml 10.937 
4 ml 10.127 
6 ml 12.558 
SEM 1.725 
Note: a-b dissimilar letters in each column and each 
sub-group indicated significant differences (p < 0.05) 
 
Serum biochemical profile  
 
There was no significant difference in glucose 
concentration during treatment (p >0.05). By 
increasing the concentrations of metformin, the 
chicken’s triglycerides increased (p <0.05). 
Cholesterol was not significantly different during 
treatment (p > 0.05). Chickens’ LDL was 
increased with increasing concentrations of 
metformin (p <0.05). Different concentrations of 
HDL and VLDL were observed by increasing 
concentrations of metformin (Table 5). 
 
Table 5: Effect of metformin on serum biochemical 
parameters in the first experiment (n = 32) 
 
VLDL HDL  LDL  Cholesterol  Triglycerides  Glucose Metformin 
dose  18.32a  75.375a  49.695b  106.75a  91.6a  276.7  0 ml 
17.3903b  71.75ab  51.89b  106.25a  86.951b  276.72  2 ml 
17.758ab  69.625b  66.133a  118a  88.79ab  284.5  4 ml 
18.0835ab  74.75a  61.209ab  117.875a  90.418ab  281.74  6 ml 
0.22  1.66  4.2  4.148  1.14  13.77  SEM 
Note: a-b dissimilar letters in each column and each 
sub-group indicated significant differences (p < 0.05)  
 
In the second experiment, no significant 
difference was observed in blood parameters 




In-ovo feeding is an important factor in improving 
intestinal growth of the fetus and newly hatched 
chicks. It also improves hatchability, growth, 
body and increases muscles weight. It reduces 
chick mortality after hatching. On fetal day 16 or 
17, the amniotic fluid is used orally and with the 
arrival of nutrients to the intestines their function 
is improved; therefore, injecting nutrients into the 
amnion before hatching can be used as an 
external feed before the injection so that the 
injected nutrients are digested and absorbed in 
the intestinal tissues [10,11]. 
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Table 6: Effect of metformin on serum biochemical parameters in the second experiment (n = 32) 
 
VLDL HDL  LDL  Cholesterol  Triglycerides  Glucose Metformin dose  
17.92  77.5  88.75  100.875  89.625  203.750  0 ml 
17.57  757.75  89.375  101.5  87.875  221  2 ml 
17.2  78.42  91.429  98.75  87.875  216.75  4 ml 
16.8  73.125  96.625  107.5  84  206.625  6 ml 
0.98  0.98  0.98  3.18  1.93  6.25  SEM 
Note: a-b dissimilar letters in each column and each sub-group indicated significant differences (p <0.05) 
 
AMPK is an enzyme that affects the energy 
balance of cells. With the activation of this 
enzyme, the signaling path from the 
hypothalamus to the target organs, including the 
brain, liver and muscles, is stimulated. Metformin 
activates protein kinase AMP in the hepatic cells; 
in this study, with increasing concentrations of 
metformin in the first experiment (chicken), 
AMPK gene expression was significant but it was 
not significant in the second experiment 
(chicken). Researchers found that the reduced 
Acetyl-CoA carboxylase activity oxidized the fatty 
acids and stopped lipogenic enzymes’ 
expression [12]. Many studies have shown that 
AMPK disables Acetyl-CoA carboxylase and 
limits its activity in lipogenesis [13]. Zhou et al 
[12] demonstrated that AMPK inhibitor hinders 
the activity of metformin to prevent hepatic 
glucose production.  
 
In the study by Ashwell and McMurtry [14], 
AMPK increased the reabsorption of glucose by 
the muscles. The duo’s results were consistent 
with this study in that they found that metformin 
reduces triglyceride level in non-esterified fatty 
acid (NEFA). Decreasing sensitivity to glucose 
leads the source of energy to the lipids and 
disabling Acetyl-CoA carboxylase increases 
oxidation of fatty acids by reducing plasma 
triglycerides. Their research showed that within 
the first three hours of metformin intake, the feed 
intake, insulin, glucose and triglyceride 
concentrations reduced. But in this study, by 
increasing concentrations of injectable metformin 
during the first experiment, LDL concentration 
increased and triglyceride levels decreased 
significantly. 
 
Results of the present study showed that in the 
second experiment, there were no significant 
changes in treatment for blood parameters (p 
>0.05). It is expected that by injecting metformin, 
after hatching and the beginning of breeding, 
especially in the first week, there is a significant 
reduction in infections caused by the yolk sac 
and umbilical cord due to the intake of yolk 
nutrients by embryos. In a study on diabetic rats, 
it was seen that by administering alloxan, an 
injection of metformin dose of 150 mg/kg 
reduced blood glucose, triglycerides, total 
cholesterol, LDL and VLDL and increased serum 
HDL significantly [15]. However, the results of 
this study showed that in the first experiment, by 
increasing concentrations of metformin, the 
levels of LDL increased and triglycerides, HDL 
and VLDL decreased.  
 
During embryonic development, metformin 
adjusts fat metabolism pathways by activating 
the AMPK signaling pathway. Activation of the 
AMPK signaling pathway may increase ATGL 
protein expression, fatty acid β-oxidation, 
glucose transport and, thus, ATP generation [16]. 
Besides, lipolytic enzyme, metformin is also a 
potential AMPK activator [17]. The activation of 
AMPK phosphorylates ACC and then inhibits its 
activity; this results in a decrease in malonyl-CoA 
synthesis. The reduction of malonyl CoA may 
stimulate transportation of fatty acids into the 
mitochondria for β-oxidation via upregulation of 
the transporter of fatty acids, CPT1 [18]. Indeed, 
metformin lifted the phosphorylation of AMPK 
and ACC and the expression of CPT1, and it 
implies that metformin probably raises fatty acid 
β-oxidation and that is why the free fatty acid 
levels were decreased in a dose dependent 
manner both in the plasma and the liver. Here, 




Metformin increases fatty acid oxidation of chick 
yolk and accelerates fetal use of this energy 
source by activating AMPK enzyme. This drug, 
when injected on day 16, increases fetal yolk 
consumption by the fetus. However, AMPK gene 
is not expressed in 42-day-old chickens due to 
the time lag between injection and the time of the 
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